ID: ALA5286365

Max Phase: Preclinical

Molecular Formula: C19H18ClFN2

Molecular Weight: 328.82

Associated Items:

Representations

Canonical SMILES:  CNCc1cc(-c2ccccc2F)n(-c2ccc(Cl)cc2)c1C

Standard InChI:  InChI=1S/C19H18ClFN2/c1-13-14(12-22-2)11-19(17-5-3-4-6-18(17)21)23(13)16-9-7-15(20)8-10-16/h3-11,22H,12H2,1-2H3

Standard InChI Key:  HWFGUHVZRIHPIM-UHFFFAOYSA-N

Associated Targets(Human)

Serotonin transporter 12625 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 328.82Molecular Weight (Monoisotopic): 328.1143AlogP: 4.96#Rotatable Bonds: 4
Polar Surface Area: 16.96Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.28CX LogP: 5.01CX LogD: 3.14
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.72Np Likeness Score: -1.19

References

1. Wunnava AUR, Kurati SP, Eswar Kumar K, Muthyala MKK..  (2023)  Design, synthesis and evaluation of 1-(1,5-bis(4-substituted phenyl)-2-methyl-1H-pyrrol-3-yl)-N-methylmethanamines as SERT inhibitors with potential antidepressant action.,  14  (2.0): [PMID:36846366] [10.1039/d2md00243d]

Source